Correlation Between Biofrontera Warrants and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Biofrontera Warrants and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Pasithea Therapeutics.
Diversification Opportunities for Biofrontera Warrants and Pasithea Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Biofrontera and Pasithea is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Biofrontera Warrants and Pasithea Therapeutics
Assuming the 90 days horizon Biofrontera Warrants is expected to generate 18.15 times more return on investment than Pasithea Therapeutics. However, Biofrontera Warrants is 18.15 times more volatile than Pasithea Therapeutics Corp. It trades about 0.23 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.05 per unit of risk. If you would invest 3.90 in Biofrontera Warrants on August 28, 2024 and sell it today you would earn a total of 4.64 from holding Biofrontera Warrants or generate 118.97% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 55.0% |
Values | Daily Returns |
Biofrontera Warrants vs. Pasithea Therapeutics Corp
Performance |
Timeline |
Biofrontera Warrants |
Pasithea Therapeutics |
Biofrontera Warrants and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biofrontera Warrants and Pasithea Therapeutics
The main advantage of trading using opposite Biofrontera Warrants and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.Biofrontera Warrants vs. Biofrontera | Biofrontera Warrants vs. Pasithea Therapeutics Corp | Biofrontera Warrants vs. Inspira Technologies Oxy | Biofrontera Warrants vs. Bluejay Diagnostics |
Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Scpharmaceuticals | Pasithea Therapeutics vs. Milestone Pharmaceuticals | Pasithea Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |